The trial evaluated Blenrep (belantamab mafodotin), in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, bortezomib plus PomDex. A pre-specified interim ...
While Blenrep has been granted accelerated approval by the FDA for multiple myeloma patients who have received at least four prior therapies – including an anti-CD38 monoclonal antibody, a ...
Blenrep, which is predicted by analysts to produce revenues of around $1.5bn in 2026, is an antibody-drug conjugate that works by targeting B-cell maturation antigen (BCMA), a protein commonly ...
In the third quarter, GSK saw weaker-than-expected sales for its respiratory syncytial virus (RSV) and shingles vaccines.
GSK reported a mixed third-quarter performance on Wednesday, with a notable boost from specialty medicines helping to offset ...
News, December 01, 2022 Alert Blenrep for Multiple Myeloma Withdrawn From US Market The manufacturer is pulling the drug from the market at the request of the FDA following disappointing results ...
We were particularly pleased to see the momentum now being established in our oncology business, and I'm delighted that we filed Blenrep in Europe, Japan, and the U.S. in the quarter. We also ...
Nov. 8, 2024 — Biologists found what makes some types of tomatoes more heat-tolerant, yielding insights that could help crops adapt to climate ... Deep Ocean Clues to a Million-Year-Old Ice Age ...
Justin Welby, the leader of 85 million Anglicans worldwide, announced his resignation days after a report found he had taken insufficient action over claims of abuse. By Stephen Castle and Mark ...
The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. Antibody drug conjugates ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback